Assesment of the effect of tranexamic acid on perioperative bleeding in patients undergoinig adenotonsillectomy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180404039191N1

Enrollment

160

Registered

2018-04-30

Start date

2017-09-23

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoid. Hypertrophy of adenoids and Enlargement of adenoids

Interventions

Intervention 1: Intervention group: Patients who received tran examic acid: After IV line taking, 5ml/kg crystaloid fluid, 0.05mg/kg midazolam and 1µg/kg remifentanil will be injected. The general ane

Eligibility

Sex/Gender

All

Age

6 Months to 14 Years

Inclusion criteria

Inclusion criteria: Normal U/A Recurrent tonsilitis Chronic tonsilitis Sleep obstructive apnea syndrome Tonsilar hypertrophy Dysphagia

Exclusion criteria

Exclusion criteria: Allergy to tranexamic acid Hematuria history Patients disagreement to attend in study

Design outcomes

Primary

Measure	Time frame
The bleeding volume which is evaluated in first 24h after surgery. Timepoint: First 24h after surgery. Method of measurement: Graduated cylinder.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehnam Shamsadin

Zahedan University of Medical Sciences

b.shamsaddin@zaums.ac.ir+98 54 3329 5744

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026